Objective. To study prescription patterns of biological treatment in rheumatoid arthritis (RA) patients in southern Sweden, a region with no formal or economic restrictions for the use of biological treatment in rheumatological diseases. Specifically, we studied conformity with the national Swedish guidelines for biologics in (RA). Methods. Rheumatologists in southern Sweden contribute to a voluntary register on the use of biologics in treating arthritis patients (the South Swedish Arthritis Treatment Group (SSATG)). This register covers>90 % of all the prescriptions of biologics for arthritis patients in the region. The treatment of 1839 patients (2704 treatment occasions) was recorded in the SSATG register during 1999-2006. Baseline ch...
Objective. The prescription of biologic drugs for rheumatoid arthritis (RA) patients has varied cons...
Objectives: To study the impact of the introduction of biological DMARDs (bDMARDs) and associated rh...
BACKGROUND: Understanding the evolving treatment patterns in patients with rheumatoid arthritis (RA)...
Objective: To study prescription patterns of biological treatment in rheumatoid arthritis ( RA) pati...
Objectives. To gain updated estimates of prevalence and incidence of RA and proportion on biological...
Methods: A continuously updated population-based RA register was established in the city of Malmo, s...
OBJECTIVE: In Switzerland, the prescription of biologic antirheumatic agents in rheumatoid arthritis...
OBJECTIVES: Treatment options for rheumatoid arthritis (RA) include conventional synthetic disease-m...
Objective: To identify factors that influence treatment adjustments and adoption of a treat-to-targe...
Rheumatoid arthritis (RA) is a chronic, inflammatory, auto-immune disease with an unpredictable and ...
PURPOSE: To study 21st century trends in healthcare utilisation by patients with rheumatoid arthriti...
OBJECTIVES: To estimate the prevalence of Danish RA patients currently on biologic monotherapy and c...
OBJECTIVES: The aim of this study of patients with RA in Sweden was to investigate secular trends in...
Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follo...
Introduction: One aim of modern pharmacologic treatment in rheumatoid arthritis (RA) is to prevent j...
Objective. The prescription of biologic drugs for rheumatoid arthritis (RA) patients has varied cons...
Objectives: To study the impact of the introduction of biological DMARDs (bDMARDs) and associated rh...
BACKGROUND: Understanding the evolving treatment patterns in patients with rheumatoid arthritis (RA)...
Objective: To study prescription patterns of biological treatment in rheumatoid arthritis ( RA) pati...
Objectives. To gain updated estimates of prevalence and incidence of RA and proportion on biological...
Methods: A continuously updated population-based RA register was established in the city of Malmo, s...
OBJECTIVE: In Switzerland, the prescription of biologic antirheumatic agents in rheumatoid arthritis...
OBJECTIVES: Treatment options for rheumatoid arthritis (RA) include conventional synthetic disease-m...
Objective: To identify factors that influence treatment adjustments and adoption of a treat-to-targe...
Rheumatoid arthritis (RA) is a chronic, inflammatory, auto-immune disease with an unpredictable and ...
PURPOSE: To study 21st century trends in healthcare utilisation by patients with rheumatoid arthriti...
OBJECTIVES: To estimate the prevalence of Danish RA patients currently on biologic monotherapy and c...
OBJECTIVES: The aim of this study of patients with RA in Sweden was to investigate secular trends in...
Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follo...
Introduction: One aim of modern pharmacologic treatment in rheumatoid arthritis (RA) is to prevent j...
Objective. The prescription of biologic drugs for rheumatoid arthritis (RA) patients has varied cons...
Objectives: To study the impact of the introduction of biological DMARDs (bDMARDs) and associated rh...
BACKGROUND: Understanding the evolving treatment patterns in patients with rheumatoid arthritis (RA)...